Breakthrough science. One moment, one day, one person at a time.

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

Genentech Access Solutions offers coverage support, patient assistance, other useful information.

Genentech has multiple medicines for serious and life-threatening medical conditions. Access information and resources on each of our medicines

Rigorous and groundbreaking science has always been at the core of what we do at Genentech. Our R&D activities are focused on applying excellent science to discover and develop potential new medicines with the goal of becoming first-in-class or best-in-class therapeutics.

The little things we do every day add up to big breakthroughs. Making a difference in the lives of millions starts when you make a change in yours.

At Genentech, we are deeply committed to addressing barriers to clinical trial participation, and work to recruit more representative populations into clinical research, enhancing personalized healthcare and establishing purpose-driven partnerships.

Genentech pioneered the biotechnology industry and revolutionized treatment for some of the most complex health problems. Our transformational discoveries include the first personalized medicine for cancer and the first medicine for primary progressive multiple sclerosis.

Phone: 1 (877) GENENTECH (436-3683) Hours: Monday - Friday, 6am - 5pm PST. Report an Adverse Event. Report a side effect or harmful experience while taking a Genentech medicine. Phone: (888) 835-2555 Hours: Monday - Friday, 5am - 5pm PST. Mail: Genentech US Drug Safety 1 DNA Way Mailstop 258A South San Francisco, CA 94080. Fax: (650) 225-4630

Feb 4, 2025 · Genentech is researching and developing new treatments for people living with a range of eye diseases that cause significant visual impairment and blindness, including wet age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), geographic atrophy (GA) and other retinal diseases.